Resources

Training

Implementation of an OUD Treatment Program in the ED | September 26, 2023

Date of Presentation: September 26, 2023

Type: Training  

Audience: Clinical  

Program: Emergency Medicine with Rural and Indigenous Communities/IHS ECHO Program  

Keywords: #bridge  #bup  #buprenorphine  #ed  #opioid  #OUD  

In this presentation, Dr. Kathryn Hawk, attending physician in the Yale New Haven Hospital Emergency Department and an Associate Professor in the Department of Emergency Medicine, the Yale School of Public Health and the Program in Addiction Medicine, discusses Opioid Use Disorder (OUD) bridge services in the Emergency Department (ED), implementation strategies, collaboration, and support and resources.

Presented by:

Kathryn Hawk, MD, MHS | Randolph R. Knight, MD, FACEP | Ryan Buckley, MD

Kathryn Hawk, MD, MHS is an attending physician in the Yale New Haven Hospital Emergency Department and an Associate Professor in the Department of Emergency Medicine, the Yale School of Public Health and the Program in Addiction Medicine. She was a National Institute on Drug Abuse (NIDA) K12 sponsored Drug use, Addiction and HIV Research (DAHRS) Scholar, and is board certified in emergency and addiction medicine. She completed her residency training and research fellowship in the Yale University Department of Emergency Medicine. Her research primarily focuses on the design, testing and implementation of evidence based-care for ED patients with substance use disorders, with a focus on initiating medications for the treatment of opioid and alcohol use disorder in the ED and maximizing effective linkage to ongoing treatment using innovative strategies. Her research on quality improvement and reducing opioid-associated mortality through data linkages, overdose prevention and harm reduction strategies, implementation-facilitation ED-initiated buprenorphine for opioid use disorder, initiating treatment for alcohol use disorder in the ED and the dissemination of evidence-based best practices for care of patients with addiction has been funded by NIDA, the NIDA Clinical Trials Network, Centers for Disease Control and Prevention (CDC), Emergency Medicine Foundation (EMF), Foundation for Opioid Response (FORE), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Resources Provided:

Date added: September 8, 2023